FDA Approves First Medication for Obstructive Sleep Apnea - FDA.gov
- FDA Approves First Medication for Obstructive Sleep Apnea FDA.gov
- FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity Investors | Eli Lilly and Company
- F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea The New York Times
- Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S. STAT
- The First Sleep Apnea Drug Is Here TIME